CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis
Clinical trial NCT02965118 · COMPLETED
Trial details
- NCT number
- NCT02965118
- Sponsor
- Amorepacific Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-11-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.